Lumofridetten en es it fr

Lumofridetten Brand names, Lumofridetten Analogs

Lumofridetten Brand Names Mixture

  • No information avaliable

Lumofridetten Chemical_Formula


Lumofridetten RX_link

No information avaliable

Lumofridetten fda sheet

Lumofridetten msds (material safety sheet)

Lumofridetten MSDS

Lumofridetten Synthesis Reference

Hoerlein, U.S. Pat. 1,025,872 (1912)

Lumofridetten Molecular Weight

232.235 g/mol

Lumofridetten Melting Point

174 oC

Lumofridetten H2O Solubility

<0.01 g/100 mL

Lumofridetten State


Lumofridetten LogP


Lumofridetten Dosage Forms

Tablet; Elixir

Lumofridetten Indication

For the treatment of Epilepsy

Lumofridetten Pharmacology

Phenobarbital, the longest-acting barbiturate, is used for its anticonvulsant and sedative-hypnotic properties in the management of all seizure disorders except absence (petit mal).

Lumofridetten Absorption

Absorbed in varying degrees following oral, rectal or parenteral administration. The salts are more rapidly absorbed than are the acids. The rate of absorption is increased if the sodium salt is ingested as a dilute solution or taken on an empty stomach

Lumofridetten side effects and Toxicity

CNS and respiratory depression which may progress to Cheyne-Stokes respiration, areflexia, constriction of the pupils to a slight degree (though in severe poisoning they may wshow paralytic dilation), oliguria, tachycardia, hypotension, lowered body temperature, and coma. Typical shock syndrome (apnea, circulatory collapse, respiratory arrest, and death) may occur.

Lumofridetten Patient Information


Practitioners should give the following information and instructions to patients receiving barbiturates:

1. The use of phenobarbital carries with it an associated risk of psychological and/or physical dependence.
The patient should be warned against increasing the dose of the drug without consulting a physician.

2. Phenobarbital may impair mental and/or physical abilities required for the performance of potentially
hazardous tasks (e.g., driving, operating machinery, etc.).

3. Alcohol should not be consumed while taking phenobarbital. Concurrent use of phenobarbital with other
CNS depressants (e.g., alcohol, narcotics, tranquilizers, and antihistamines) may result in additional CNS

Lumofridetten Organisms Affected

Humans and other mammals